Principles of plant-based vaccines

Genetically Engineered Plants as a Source of Vaccines Against Wide Spread Diseases: An Integrated View

Volumn , Issue , 2014, Pages 1-14

  Govea Alonso, Dania O ^a   Cardineau, Guy A ^b   Rosales Mendoza, Sergio ^a  

^a UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

^b SCHOOL OF ENGINEERING AND SCIENCES   (Mexico)

Author keywords

Antigenic protein; Expression host; Oral vaccine; Plant cell; Vaccination

Indexed keywords

EID: 84929877434     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4939-0850-9_1     Document Type: Chapter

References (55)

1. Alvarez ML, Pinyerd HL, Crisantes JD, Rigano MM, Pinkhasov J, Walmsley AM, Mason HS, Cardineau GA (2006) Plant-made subunit vaccine against pneumonic and bubonic plague is orally immunogenic in mice. Vaccine 24:2477-2490
2. Buetow DE, Korban SS (2000) Transgenic plants producing viral and bacterial antigens. AgBiotech Reviews, http://www.agrobiotechnet.com/Reviews.asp?action=display&openMenu=relatedite ms&ReviewID=708&Year=2000
3. Curtiss R III, Cardineau GA (1997) Oral immunization by transgenic plants. United States Patent 5, 654, 184
4. Daniell H, Kumar S, Dufourmantel N (2005) Breakthrough in chloroplast genetic engineering of agronomically important crops. Trends Biotechnol 23:238-245
5. Dormitzer PR, Ulmer JB, Rappuoli R (2008) Structure-based antigen design: a strategy for next generation vaccines. Trends Biotechnol 26:659-667
6. Drake PM, Thangaraj H (2010) Molecular farming, patents and access to medicines. Expert Rev Vaccines 9:811-819
7. Earley KW, Haag JR, Pontes O, Opper K, Juehne T, Song K, Pikaard CS (2006) Gateway-compatible vectors for plant functional genomics and proteomics. Plant J 45:616-629
8. Fischer R, Stoger E, Schillberg S, Christou P, Twyman RM (2004) Plant-based production of biopharmaceuticals. Curr Opin Plant Biol 7:152-158
9. Fleischmann RD, Adams MD, White O, Clayton RA, Kirkness EF, Kerlavage AR, Bult CJ, Tomb JF, Dougherty BA, Merrick JM et al (1995) Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science 269:496-512
10. Fraser CM, Rappuoli R (2005) Application of microbial genomic science to advanced therapeutics. Annu Rev Med 56:459-474
11. Gasteiger G, Kastenmuller W, Ljapoci R, Sutter G, Drexler I (2007) Cross-priming of cytotoxic T cells dictates antigen requisites for modified vaccinia virus Ankara vector vaccines. J Virol 81:11925-11936
12. Giddings G, Allison G, Brooks D, Carter A (2000) Transgenic plants as factories for biopharmaceuticals. Nat Biotechnol 18:1151-1155
13. Gleba Y, Marillonnet S, Klimyuk V (2004) Engineering viral expression vectors for plants: the 'full virus' and the 'deconstructed virus' strategies. Curr Opin Plant Biol 7:182-188
14. Gleba Y, Klimyuk V, Marillonnet S (2005) Magnifection-a new platform for expressing recombinant vaccines in plants. Vaccine 23:2042-2048
15. Goldstein DA, Thomas JA (2004) Biopharmaceuticals derived from genetically modified plants. QJM 97:705-716
16. Gómez E, Zoth SC, Berinstein A (2009) Plant-based vaccines for potential human application: a review. Hum Vaccine 5:738-744
17. Grandi G, Nagy E (2012) Finding protective bacterial antigens. In: von Gabain A, Christoph K (eds) Development of novel vaccines. Skills, knowledge and translational technologies. Springer, Wien
18. Gustafsson C, Govindarajan S, Minshull J (2004) Codon bias and heterologous protein expression. Trends Biotechnol 22:346-353
19. Hefferon KL (2012) Plant virus expression vectors set the stage as production platforms for biopharmaceutical proteins. Virology 433:1-6
20. Hoover DM, Lubkowski J (2002) DNAWorks: an automated method for designing oligonucleotides for PCR-based gene synthesis. Nucleic Acids Res 30:e43
21. Horsch RB, Fraley RT, Rogers SG, Sanders PR, Lloyd A (1985) A simple and general method for transferring genes into plants. Science 227:1229-1231
22. Howard JA (2005) Commercialization of biopharmaceutical and bioindustrial proteins from plants. Crop Sci 45:468-472
23. Jenner E (1798) An enquiry into the causes and effects of the variolae vaccinae, a disease discovered in some of the western counties of England, particularly Gloucestershire, and known by the name of the cow pox. Sampson Low, London
24. Jenner E (1801) The origin of the vaccines inoculation. Shury, London
25. Karimi M, Inzé D, Depicker A (2002) GATEWAY vectors for Agrobacterium-mediated plant transformation. Trends Plant Sci 7:193-195
26. Korban SS (2002) Trargeting and expression of antigenic proteins in transgenic plants for production of edible oral vaccines. In Vitro Cell Dev Biol Plant 38:231-236
27. Liljeqvist S, Ståhl S (1999) Production of recombinant subunit vaccines: protein immunogens, live delivery systems and nucleic acid vaccines. J Biotechnol 73:1-33
28. Lugade AA, Kalathil S, Heald JL, Thanavala Y (2010) Transgenic plant-based oral vaccines. Immunol Invest 39:468-482
29. Ma JK-C, Drake PMW, Christou P (2003) Genetic modification: the production of recombinant pharmaceutical proteins in plants. Nat Rev Genet 4:794-805
30. Magee AM, Kavanagh TA (2002) Plastid genes transcribed by the nucleus-encoded plastid RNA polymerase show increased transcript accumulation in transgenic plants expressing a chloroplast-localized phage T7 RNA polymerase. J Exp Bot 53:2341-2349
31. Mestecky J, Nguyen H, Czerkinsky C, Kiyono H (2008) Oral immunization: an update. Curr Opin Gastroenterol 24:713-719
32. Moriel DG, Scarselli M, Serino L, Mora M, Rappuoli R, Masignani V (2008) Genome-based vaccine development: a short cut for the future. Hum Vaccin 4:184-188
33. Moutaftsi M, Peters B, Pasquetto V, Tscharke DC, Sidney J, Bui HH, Grey H, Sette A (2006) A consensus epitope prediction approach identifies the breadth of murine T (CD8 +)-cell responses to vaccinia virus. Nat Biotechnol 24:817-819
34. Moutaftsi M, Salek-Ardakani S, Croft M, Peters B, Sidney J, Grey H, Sette A (2009) Correlates of protection efficacy induced by vaccinia virus-specific CD8+ T-cell epitopes in the murine intranasal challenge model. Eur J Immunol 39:717-22
35. Mowat AM, Viney JL (1997) The anatomical basis of intestinal immunity. Immunol Rev 156:145-166
36. Pathi K, Tula S, Tuteja N (2013) High frequency regeneration via direct somatic embryogenesis and efficient Agrobacterium-mediated genetic transformation of tobacco. Plant Signal Behav 8:e24354
37. Pelosi A, Shepherd R, Walmsley AM (2012) Delivery of plant-made vaccines and therapeutics. Biotechnol Adv 30:440-448
38. Penney CA, Thomas DR, Deen SS, Walmsley AM (2011) Plant-made vaccines in support of the millennium development goals. Plant Cell Rep 30:789-798
39. Rao AQ, Bakhsh A, Kiani S, Shahzad K, Shahid AA, Husnain T, Riazuddin S (2009) The myth of plant transformation. Biotechnol Adv 27:753-763
40. Rosales-Mendoza S, Soria-Guerra RE, López-Revilla R, Moreno-Fierros L, Alpuche-Solís AG (2008) Ingestion of transgenic carrots expressing the Escherichia coli heat-labile enterotoxin B subunit protects mice against cholera toxin challenge. Plant Cell Rep 27:79-84
41. Rueckert C, Guzmán CA (2012) Vaccines: from empirical development to rational design. PLoS Pathog 8:e1003001
42. Salyaev RK, Rigano MM, Rekoslavskaya NI (2010) Development of plant-based mucosal vaccines against wide spread infectious diseases. Expert Rev Vaccines 9:937-946
43. Sette A, Rappuoli R (2010) Reverse vaccinology: developing vaccines in the era of genomics. Immunity 33:530-541
44. Sharma AK, Sharma MK (2009) Plants as bioreactors: recent developments and emerging opportunities. Biotechnol Adv 27(6):811-832
45. Slater A, Scott NW, Fowler MR (2008) Plant biotechnology: the genetic manipulation of plants. Oxford University Press, Oxford, 376 p
46. Soria-Guerra RE, Moreno-Fierros L, Rosales-Mendoza S (2011) Two decades of plant-based candidate vaccines: a review of the chimeric protein approaches. Plant Cell Rep 30:1367-1382
47. Staats HF, Jackson RJ, Marinaro M, Takahashi I, Kiyono H, McGhee JR (1994) Mucosal immunity to infection with implications for vaccine development. Curr Opin Immunol 6:572-583
48. Tacket CO, Mason HS, Losonsky G, Clements JD, Levine MM, Arntzen CJ (1998) Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato. Nat Med 4:607-609
49. Tacket CO, Mason HS, Losonsky G, Estes MK, Levine MM, Arntzen CJ (2000) Human immune responses to a novel norwalk virus vaccine delivered in transgenic potatoes. J Infect Dis 182:302-305
50. Takahashi I, Nochi T, Yuki Y, Kiyono H (2009) New horizon of mucosal immunity and vaccines. Curr Opin Immunol 21:352-358
51. Thanavala Y, Mahoney M, Pal S, Scott A, Richter L, Natarajan N, Goodwin P, Arntzen CJ, Mason HS (2005) Immunogenicity in humans of an edible vaccine for hepatitis B. Proc Natl Acad Sci U S A 102:3378-3382
52. Tiwari S, Verma PC, Singh PK, Tuli R (2009) Plants as bioreactors for the production of vaccine antigens. Biotechnol Adv 27:449-467
53. Walden R, Schell J (1990) Techniques in plant molecular biology-progress and problems. Eur J Biochem 192:563-576
54. Wycoff KL (2005) Secretory IgA antibodies from plants. Curr Pharm Des 11:2429-2437
55. Yusibov V, Streatfield SJ, Kushnir N (2011) Clinical development of plant-produced recombinant pharmaceuticals: vaccines, antibodies and beyond. Hum Vaccin 7:313-321